SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Dynavax Technologies Corporation of

  SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their
  Investment in Dynavax Technologies Corporation of Class Action Lawsuit and
  Deadline of August 19, 2013 to Seek Lead Plaintiff Position

Business Wire

NEW YORK -- July 22, 2013

Levi & Korsinsky announces that a class action lawsuit has been commenced in
the United States District Court for the Northern District of California on
behalf of investors who purchased Dynavax Technologies Corporation (“Dynavax”
or the “Company”) (Nasdaq: DVAX) stock between April 26, 2012 and June 10,
2013.

For more information, click here: 
http://zlk.9nl.com/dynavax-technologies-dvax/.

The complaint alleges that defendants violated federal securities laws by
issuing materially false and misleading statements concerning the viability of
their drug HEPLISAV. In particular, it is alleged that during the Class Period
Dynavax concealed from the public that: (1) the clinical trial for HEPLISAV
was flawed because it was not representative of the US population and lacked
information regarding concomitant use of HEPLISAV with other vaccines; (2)
Dynavax failed to provide the FDA with sufficient data concerning its
manufacturing processes and controls for HEPLISAV.

On June 10, 2013, Dynavax disclosed that the FDA required additional data
regarding the safety of Heplisav before it could further review the drug for
potential approval.

If you suffered a loss in Dynavax you have until August 19, 2013  to request
that the Court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff. To obtain
additional information, contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (877) 363-5972, or visit
http://zlk.9nl.com/dynavax-technologies-dvax/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.

Contact:

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 866-367-6510
www.zlk.com